Alpha7 nAChR agonists for treating or preventing metabolic disorders

Details for Australian Patent Application No. 2008283813 (hide)

Owner Targacept, Inc. Medical College of Georgia

Inventors Bencherif, Merouane; Marrero, Mario B.

Agent FB Rice

Pub. Number AU-A-2008283813

PCT Pub. Number WO2009/018511

Priority 60/953,614 02.08.07 US; 60/971,654 12.09.07 US; 60/953,610 02.08.07 US; 60/953,613 02.08.07 US

Filing date 1 August 2008

Wipo publication date 5 February 2009

International Classifications

A61K 31/4545 (2006.01)

A61P 3/00 (2006.01) Drugs for disorders of the metabolism

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

Event Publications

25 February 2010 PCT application entered the National Phase

  PCT publication WO2009/018511 Priority application(s): WO2009/018511

25 March 2010 Alteration of Name

  The name of the applicant has been altered to Targacept, Inc.; Medical College of Georgia Research Institute, Inc.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008283824-High hardness, high toughness ironbase alloys and methods for making same

2008283810-Nanothin polymer films with selective pores and method of use thereof